血清淀粉樣P物質(zhì)(SAP)多克隆抗體
Polyclonal Antibody to Serum Amyloid P Component (SAP)
APCS; PTX2; Pentaxin-Related; 9.5S Alpha-1-Glycoprotein
- 編號PAB539Hu02
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原RPB539Hu02-血清淀粉樣P物質(zhì)(SAP)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度1mg/ml
- 且適物種-
- 應(yīng)用WB; IHC
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 598¥ 1394¥ 1992¥ 4980¥ 19920
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
DAB staining on IHC-P; Samples: Human Liver Tissue; Primary Ab: 30μg/ml Rabbit Anti-Human SAP Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
DAB staining on IHC-P;
Samples: Human Glioma Tissue;
Primary Ab: 30μg/ml Rabbit Anti-Human SAP Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
DAB staining on IHC-P;
Samples: Human Kidney Tissue;
Primary Ab: 30μg/ml Rabbit Anti-Human SAP Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
DAB staining on IHC-P;
Samples: Human Stomach cancer Tissue;
Primary Ab: 30μg/ml Rabbit Anti-Human SAP Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
DAB staining on IHC-P;
Samples: Human Liver cancer Tissue;
Primary Ab: 30μg/ml Rabbit Anti-Human SAP Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
DAB staining on IHC-P;
Samples: Human Lung cancer Tissue;
Primary Ab: 30μg/ml Rabbit Anti-Human SAP Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
Figure. Western Blot; Sample: Recombinant SAP, Human.
Figure. Western Blot; Sample: Lane1: Human Serum; Lane2: Human Urine.
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對SAP的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別SAP。
用法
Western blotting: 0.01-3μg/mL;
Immunohistochemistry: 5-30μg/mL;
Immunocytochemistry: 5-30μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB539Hu01 | 血清淀粉樣P物質(zhì)(SAP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB539Hu02 | 血清淀粉樣P物質(zhì)(SAP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB539Hu01 | 血清淀粉樣P物質(zhì)(SAP)多克隆抗體 | WB; IHC |
| PAB539Hu02 | 血清淀粉樣P物質(zhì)(SAP)多克隆抗體 | WB; IHC |
| LAB539Hu81 | 血清淀粉樣P物質(zhì)(SAP)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| LAB539Hu71 | 血清淀粉樣P物質(zhì)(SAP)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAB539Hu22 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | IHC |
| MAB539Hu23 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB539Hu24 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB539Hu25 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAB539Hu21 | 血清淀粉樣P物質(zhì)(SAP)單克隆抗體 | IHC |
| SEB539Hu | 血清淀粉樣P物質(zhì)(SAP)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCB539Hu | 血清淀粉樣P物質(zhì)(SAP)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMB539Hu | 血清淀粉樣P物質(zhì)(SAP)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Journal of Vascular Surgery | Circulation levels of acute phase proteins in patients with Takayasu arteritis[PubMed: 20100644] |
| Journal of Proteome Research | Combined Proteomic and Metabolomic Profiling of Serum Reveals Association of the Complement System with Obesity and Identifies Novel Markers of Body Fat Mass Changes[ACS: pr2005555] |
| Liver International | Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 3-D DIGE[Pubmed: 23944848] |
| Journal of Proteome Research | Targeted proteomics predict a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective cohort study[pubmed:28112944] |
| American Journal of Reproductive Immunology | Amniotic fluid pentraxins: Potential early markers for identifying intra‐amniotic inflammatory complications in preterm pre‐labor rupture of membranes[pubmed:29193454] |
| Theranostics | Serum amyloid P component therapeutically attenuates atherosclerosis in mice via its effects on macrophages[Pubmed:29930724] |
| J Med Primatol | Proteopathic lesions in the brain of a super?\aged chimpanzee (Pan troglodytes)[34096618] |
| Clinical and Experimental Immunology | Clinical significance of differential serum-signatures for early prediction of severe dengue among Eastern Indian patients[Pubmed:35348620] |